Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Systemic Lupus Erythematosus; Psoriasis; Behcet's Disease; Wegener's Granulomatosis; Takayasu's Disease; Crohn's Disease; Ulcerative Colitis; Autoimmune Hepatitis; Sclerosing CholangitisIntervention: Drug: Interleukin 2Sponsors: Assistance Publique - Hôpitaux de Paris; ILTOO PharmaRecruiting - verified January 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arthritis | Autoimmune Disease | Behcet's Disease | Crohn's Disease | Hepatitis | Hepatitis A | Psoriasis | Research | Rheumatology | Wegener's Granulomatosis